In The Press:
Askeladden Advocates for Ability of Non-Defendant IPR Petitioners to Appeal Adverse PTAB Decisions

Patent Quality Initiative reports on amicus brief filed in support of JTEKT’s petition for rehearing en banc at the Federal Circuit Askeladden is represented by Amster Rothstein and Ebenstein LLP. Available Here.

ARE Patent Law Alert:SCOTUS AUTHORIZES FOREIGN LOST PROFITS FOR DOMESTIC INFRINGEMENT UNDER 35 USC 271(f)(2) IN WESTERNGECO v. ION

(June 25, 2018)  On June 22, 2018, the Supreme Court of the United States delivered an opinion in WesternGeco LLC v. ION Geophysical Corp., No. 16-1011, slip op. (U.S. June 22, 2018), addressing the question of whether a patent owner who proves infringement under 35 U.S.C § 271(f)(2) can recover lost foreign profits pursuant to […]

ARE Patent Law Alert:SUPREME COURT TO CLARIFY ‘ON SALE’ BAR IN HELSINN HEALTHCARE S.A. V. TEVA PHARMS. USA, INC.

On June, 25, 2018, the U.S. Supreme Court granted certiorari in Helsinn Healthcare S.A. v. Teva Pharms. USA, Inc., No. 17-1229 to address the scope of the “on-sale bar” after the Leahy-Smith America Invents Act (“AIA”). Specifically, the Court will consider whether confidential prior sales of an invention trigger the on-sale bar, and qualify as […]